ERα and ERβ affect the survival of lung cancer patients by promoting the proliferation of cancer cells [85, 86], and ERβ is expressed at higher levels than ERα in most NSCLC cell lines and tissues during cancer development [76, 87]. Here, ESR2 is linked to non-small cell lung carcinoma.